{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T04:27:09Z","timestamp":1772252829116,"version":"3.50.1"},"reference-count":46,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Korea Drug Development Fund","award":["HN21C1214"],"award-info":[{"award-number":["HN21C1214"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>PTK7 is a catalytically defective receptor protein tyrosine kinase upregulated in various cancers, including esophageal squamous cell carcinoma (ESCC). In previous studies, we observed a positive correlation between PTK7 expression levels and tumorigenicity in various ESCC cell lines and xenograft mice with ESCC KYSE-30 cells. In this study, we analyzed the effects of anti-PTK7 monoclonal antibodies (mAbs) on the tumorigenic activity in KYSE-30 cells and in mouse xenograft models. PTK7 mAb-32 and mAb-43 bind with a high affinity to the extracellular domain of PTK7. PTK7 mAbs significantly reduced three-dimensional cell proliferation, adhesion, wound healing, and migration. PTK7 mAbs also reduce chemotactic invasiveness by decreasing MMP-9 secretion. PTK7 mAbs decreased actin cytoskeleton levels in the cortical region of KYSE-30 cells. PTK7 mAbs reduced the phosphorylation of ERK, SRC, and FAK. In a mouse xenograft model of ESCC using KYSE-30 cells, PTK7 mAbs reduced tumor growth in terms of volume, weight, and the number of Ki-67-positive cells. These results demonstrated that PTK7 mAbs can inhibit the tumorigenicity of ESCC at the cellular level and in vivo by blocking the function of PTK7. Considering the anticancer activities of PTK7 mAbs, we propose that PTK7 mAbs can be used in an effective treatment strategy for PTK7-positive malignancies, such as ESCC.<\/jats:p>","DOI":"10.3390\/ijms232012195","type":"journal-article","created":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T22:21:11Z","timestamp":1665699671000},"page":"12195","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Anti-PTK7 Monoclonal Antibodies Exhibit Anti-Tumor Activity at the Cellular Level and in Mouse Xenograft Models of Esophageal Squamous Cell Carcinoma"],"prefix":"10.3390","volume":"23","author":[{"given":"Jae Hoon","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul 03722, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9432-1320","authenticated-orcid":false,"given":"Won-Sik","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul 03722, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se-Ra","family":"Lee","sequence":"additional","affiliation":[{"name":"New Drug Development Center, Osong Medical Innovation Foundation, Cheongju 28160, Chungbuk, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanggil","family":"Kim","sequence":"additional","affiliation":[{"name":"New Drug Development Center, Osong Medical Innovation Foundation, Cheongju 28160, Chungbuk, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"So-Young","family":"Choi","sequence":"additional","affiliation":[{"name":"New Drug Development Center, Osong Medical Innovation Foundation, Cheongju 28160, Chungbuk, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7300-9784","authenticated-orcid":false,"given":"Seung-Taek","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul 03722, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1042\/BST20160331","article-title":"The secret life of kinases: Insights into non-catalytic signalling functions from pseudokinases","volume":"45","author":"Jacobsen","year":"2017","journal-title":"Biochem. Soc. Trans."},{"key":"ref_2","first-page":"501","article-title":"Prospects for pharmacological targeting of pseudokinases","volume":"18","author":"Kung","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/cas.12194","article-title":"Oncogenic role of protein tyrosine kinase 7 in esophageal squamous cell carcinoma","volume":"104","author":"Shin","year":"2013","journal-title":"Cancer Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"eaag2611","DOI":"10.1126\/scitranslmed.aag2611","article-title":"A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions","volume":"9","author":"Damelin","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e12511","DOI":"10.1111\/cpr.12511","article-title":"Aptamer-targeted DNA nanostructures with doxorubicin to treat protein tyrosine kinase 7-positive tumours","volume":"52","author":"Liu","year":"2019","journal-title":"Cell Prolif."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1158\/0008-5472.CAN-09-3145","article-title":"An ErbB3 antibody, MM-121, is active in cancers with ligand-dependent activation","volume":"70","author":"Schoeberl","year":"2010","journal-title":"Cancer Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1111\/cas.14568","article-title":"The catalytically defective receptor protein tyrosine kinase EphA10 promotes tumorigenesis in pancreatic cancer cells","volume":"111","author":"Shin","year":"2020","journal-title":"Cancer Sci."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"G\u00e4rtner, S., Gunesch, A., Knyazeva, T., Wolf, P., H\u00f6gel, B., Eiermann, W., Ullrich, A., Knyazev, P., and Ataseven, B. (2014). PTK 7 is a transforming gene and prognostic marker for breast cancer and nodal metastasis involvement. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0084472"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s13577-019-00309-6","article-title":"PTK7 promotes the malignant properties of cancer stem-like cells in esophageal squamous cell lines","volume":"33","author":"Bie","year":"2020","journal-title":"Hum. Cell"},{"key":"ref_10","first-page":"3759","article-title":"PTK7 expression in triple-negative breast cancer","volume":"33","author":"Ataseven","year":"2013","journal-title":"Anticancer Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"73242","DOI":"10.18632\/oncotarget.12303","article-title":"Catalytically defective receptor protein tyrosine kinase PTK7 enhances invasive phenotype by inducing MMP-9 through activation of AP-1 and NF-\u03baB in esophageal squamous cell carcinoma cells","volume":"7","author":"Shin","year":"2016","journal-title":"Oncotarget"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Shin, W.-S., Park, M.K., Kim, J.H., Oh, S.W., Jang, J.Y., Lee, H., and Lee, S.-T. (2022). PTK7, a Catalytically Inactive Receptor Tyrosine Kinase, Increases Oncogenic Phenotypes in Xenograft Tumors of Esophageal Squamous Cell Carcinoma KYSE-30 Cells. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23042391"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"699889","DOI":"10.3389\/fonc.2021.699889","article-title":"Protein Tyrosine Kinase 7 Regulates EGFR\/Akt Signaling Pathway and Correlates With Malignant Progression in Triple-Negative Breast Cancer","volume":"11","author":"Cui","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.bmc.2016.12.026","article-title":"Development of new PTK7-targeting aptamer-fluorescent and -radiolabelled probes for evaluation as molecular imaging agents: Lymphoma and melanoma in vivo proof of concept","volume":"25","author":"Calzada","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1177\/1535370217708198","article-title":"Discovery of small molecule inhibitors of the Wnt\/\u03b2-catenin signaling pathway by targeting \u03b2-catenin\/Tcf4 interactions","volume":"242","author":"Yan","year":"2017","journal-title":"Exp. Biol. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"26399","DOI":"10.1038\/srep26399","article-title":"Rapid and sensitive detection of early esophageal squamous cell carcinoma with fluorescence probe targeting dipeptidylpeptidase IV","volume":"6","author":"Onoyama","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/jjco\/hyz034","article-title":"Systemic treatment of advanced esophageal squamous cell carcinoma: Chemotherapy, molecular-targeting therapy and immunotherapy","volume":"49","author":"Hirano","year":"2019","journal-title":"Jpn. J. Clin. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.3389\/fonc.2020.01727","article-title":"Understanding Esophageal Cancer: The Challenges and Opportunities for the Next Decade","volume":"10","author":"Yang","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"11665","DOI":"10.3390\/ijms150711665","article-title":"Protein tyrosine kinase 7 (PTK7) as a predictor of lymph node metastases and a novel prognostic biomarker in patients with prostate cancer","volume":"15","author":"Zhang","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.3892\/or.2016.4983","article-title":"PTK7 overexpression in colorectal tumors: Clinicopathological correlation and prognosis relevance","volume":"36","author":"Tian","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1158\/1078-0432.CCR-20-3605","article-title":"The Anti-HER3 mAb Seribantumab Effectively Inhibits Growth of Patient-Derived and Isogenic Cell Line and Xenograft Models with Oncogenic NRG1 Fusions","volume":"27","author":"Odintsov","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"101817","DOI":"10.1016\/j.jbc.2022.101817","article-title":"Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer","volume":"298","author":"Cha","year":"2022","journal-title":"J. Biol. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/1759-7714.12112","article-title":"New orthotopic implantation model of human esophageal squamous cell carcinoma in athymic nude mice","volume":"5","author":"Song","year":"2014","journal-title":"Thorac. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1186\/s40880-015-0046-2","article-title":"Association of insulin-like growth factor-binding protein-3 with radiotherapy response and prognosis of esophageal squamous cell carcinoma","volume":"34","author":"Luo","year":"2015","journal-title":"Chin. J. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10549-021-06272-x","article-title":"Activity of trastuzumab emtansine (T-DM1) in 3D cell culture","volume":"188","author":"Boyer","year":"2021","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fmolb.2020.00033","article-title":"Is It Time to Start Transitioning From 2D to 3D Cell Culture?","volume":"7","author":"Jensen","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.ejcb.2012.07.005","article-title":"Do cancer cells have distinct adhesions in 3D collagen matrices and in vivo?","volume":"91","author":"Geraldo","year":"2012","journal-title":"Eur. J. Cell Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"5380197","DOI":"10.1155\/2019\/5380197","article-title":"The Increased PTK7 Expression Is a Malignant Factor in Cervical Cancer","volume":"2019","author":"Sun","year":"2019","journal-title":"Dis. Markers"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Lhoumeau, A.C., Martinez, S., Boher, J.M., Monges, G., Castellano, R., Goubard, A., Doremus, M., Poizat, F., Lelong, B., and de Chaisemartin, C. (2015). Overexpression of the Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in Colorectal Cancer. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0123768"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Meng, L., Sefah, K., O\u2019Donoghue, M.B., Zhu, G., Shangguan, D., Noorali, A., Chen, Y., Zhou, L., and Tan, W. (2010). Silencing of PTK7 in colon cancer cells: Caspase-10-dependent apoptosis via mitochondrial pathway. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0014018"},{"key":"ref_32","first-page":"e51046","article-title":"In vitro cell migration and invasion assays","volume":"88","author":"Justus","year":"2014","journal-title":"J. Vis. Exp."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nrc1075","article-title":"Tumour-cell invasion and migration: Diversity and escape mechanisms","volume":"3","author":"Friedl","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Barillari, G. (2020). The Impact of Matrix Metalloproteinase-9 on the Sequential Steps of the Metastatic Process. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21124526"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.semcdb.2019.11.018","article-title":"Towards a structural understanding of the remodeling of the actin cytoskeleton","volume":"102","author":"Merino","year":"2020","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_36","first-page":"1997","article-title":"ERK\/MAPK signalling pathway and tumorigenesis (Review)","volume":"19","author":"Guo","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4238\/gmr.15038026","article-title":"Activation of Src tyrosine kinase in esophageal carcinoma cells in different regulatory environments and corresponding occurrence mechanism","volume":"15","author":"Yu","year":"2016","journal-title":"Genet. Mol. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/sj.bjc.6601050","article-title":"FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma","volume":"89","author":"Miyazaki","year":"2003","journal-title":"Br. J. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"12960","DOI":"10.1096\/fj.201900932R","article-title":"Catalytically inactive receptor tyrosine kinase PTK7 activates FGFR1 independent of FGF","volume":"33","author":"Shin","year":"2019","journal-title":"FASEB J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4161\/cbt.22956","article-title":"Oncogenic but non-essential role of N-myc downstream regulated gene 1 in the progression of esophageal squamous cell carcinoma","volume":"14","author":"Wei","year":"2013","journal-title":"Cancer Biol. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1016\/j.bbamcr.2015.05.015","article-title":"Biphasic effect of PTK7 on KDR activity in endothelial cells and angiogenesis","volume":"1853","author":"Shin","year":"2015","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Oh, S.W., Shin, W.-S., and Lee, S.-T. (2022). Anti-PTK7 Monoclonal Antibodies Inhibit Angiogenesis by Suppressing PTK7 Function. Cancers, 14.","DOI":"10.3390\/cancers14184463"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Lucas, A.T., Moody, A., Schorzman, A.N., and Zamboni, W.C. (2021). Importance and Considerations of Antibody Engineering in Antibody-Drug Conjugates Development from a Clinical Pharmacologist\u2019s Perspective. Antibodies, 10.","DOI":"10.3390\/antib10030030"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.bbrc.2008.04.168","article-title":"Soluble PTK7 inhibits tube formation, migration, and invasion of endothelial cells and angiogenesis","volume":"371","author":"Shin","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"151","DOI":"10.14348\/molcells.2015.2229","article-title":"Galangin and kaempferol suppress phorbol-12-myristate-13-acetate-induced matrix metalloproteinase-9 expression in human fibrosarcoma HT-1080 cells","volume":"38","author":"Choi","year":"2015","journal-title":"Mol. Cells"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Varghese, F., Bukhari, A.B., Malhotra, R., and De, A. (2014). IHC Profiler: An Open Source Plugin for the Quantitative Evaluation and Automated Scoring of Immunohistochemistry Images of Human Tissue Samples. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0096801"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/20\/12195\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:53:07Z","timestamp":1760143987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/20\/12195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,13]]},"references-count":46,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["ijms232012195"],"URL":"https:\/\/doi.org\/10.3390\/ijms232012195","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,13]]}}}